Microbial proteins and lipid membranes

Microbial proteins and lipid membranes represent a broad category of therapeutic targets essential for the survival and virulence of bacteria, fungi, and viruses (StatPearls: Antibiotics, 2023). Microbial proteins include enzymes like penicillin-binding proteins (PBPs) involved in cell wall synthesis, as well as various transporters and receptors that facilitate nutrient uptake and environmental adaptation (Nature Reviews Microbiology: Bacterial cell wall synthesis, 2015). Lipid membranes provide structural integrity and serve as a selective barrier, often containing unique components such as ergosterol in fungi or lipopolysaccharides in Gram-negative bacteria (PubChem: Amphotericin B, 2024). Drugs targeting these structures typically act by inhibiting enzymatic activity (e.g., beta-lactams) or by physically disrupting the lipid bilayer (e.g., polymyxins and polyenes), leading to cell lysis (PubMed: Mechanism of action of polymyxins, 2014). While these targets are fundamental to antimicrobial therapy, their effectiveness is increasingly limited by the development of resistance mechanisms and potential toxicity to host tissues (WHO: Antimicrobial resistance, 2023). Understanding the molecular interactions at the microbial surface is critical for the design of next-generation anti-infectives.

Other names

Microbial cell surface componentsBacterial cell wall and membraneFungal cell membraneViral envelope proteins

Inhibition of cell wall synthesis by binding to penicillin-binding proteins (PBPs), disruption of membrane integrity through pore formation, and inhibition of essential metabolic enzymes (StatPearls: Antibiotics, 2023; PubMed: Mechanism of action of polymyxins, 2014).